167 related articles for article (PubMed ID: 19874322)
1. Association of HLA-DRB1* and keloid disease in an Afro-Caribbean population.
Brown JJ; Ollier WE; Arscott G; Bayat A
Clin Exp Dermatol; 2010 Apr; 35(3):305-10. PubMed ID: 19874322
[TBL] [Abstract][Full Text] [Related]
2. Positive association of HLA-DRB1*15 with keloid disease in Caucasians.
Brown JJ; Ollier WE; Thomson W; Bayat A
Int J Immunogenet; 2008 Aug; 35(4-5):303-7. PubMed ID: 18976433
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans.
Brown JJ; Ollier W; Arscott G; Ke X; Lamb J; Day P; Bayat A
Exp Dermatol; 2008 Jul; 17(7):610-3. PubMed ID: 18445023
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the influence of HLA class I and class II loci on the prevalence of keloid disease in Jamaican Afro-Caribbeans.
Ashcroft KJ; Syed F; Arscott G; Bayat A
Tissue Antigens; 2011 Nov; 78(5):390-6. PubMed ID: 21812766
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-DRB1 alleles with keloids in Chinese Han individuals.
Lu WS; Zhang WY; Li Y; Wang ZX; Zuo XB; Cai LQ; Zhu F; Wang JF; Sun LD; Zhang XJ; Yang S
Tissue Antigens; 2010 Oct; 76(4):276-81. PubMed ID: 20522201
[TBL] [Abstract][Full Text] [Related]
6. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.
Deschamps R; Paturel L; Jeannin S; Chausson N; Olindo S; Béra O; Bellance R; Smadja D; Césaire D; Cabre P
Mult Scler; 2011 Jan; 17(1):24-31. PubMed ID: 20861181
[TBL] [Abstract][Full Text] [Related]
7. An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin.
Kelly MA; Jacobs KH; Penny MA; Mijovic CH; Nightingale S; Barnett AH; Francis DA
Tissue Antigens; 1995 Mar; 45(3):197-202. PubMed ID: 7761978
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica.
Heward JM; Mijovic CH; Kelly MA; Morrison E; Barnett AH
Eur J Immunogenet; 2002 Feb; 29(1):47-52. PubMed ID: 11841488
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis.
Shih B; Bayat A
Arch Dermatol Res; 2012 Apr; 304(3):241-9. PubMed ID: 22033527
[TBL] [Abstract][Full Text] [Related]
10. Distribution of HLA-DQA1, -DQB1 and DRB1 alleles in black IDDM patients and controls from Zimbabwe.
Garcia-Pacheco JM; Herbut B; Cutbush S; Hitman GA; Zhonglin W; Magzoub M; Bottazzo GF; Kiere C; West G; Mvere D
Tissue Antigens; 1992 Sep; 40(3):145-9. PubMed ID: 1440568
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance.
da Silva SA; Mazini PS; Reis PG; Sell AM; Tsuneto LT; Peixoto PR; Visentainer JE
BMC Infect Dis; 2009 Aug; 9():134. PubMed ID: 19698125
[TBL] [Abstract][Full Text] [Related]
12. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians.
Caballero A; Alvés-León S; Papais-Alvarenga R; Fernández O; Navarro G; Alonso A
Tissue Antigens; 1999 Nov; 54(5):524-6. PubMed ID: 10599893
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls.
Mbanya JC; Sobngwi E; Mbanya DN
Eur J Immunogenet; 2001 Aug; 28(4):459-62. PubMed ID: 11532022
[TBL] [Abstract][Full Text] [Related]
14. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
15. Identification of two independent risk factors for lupus within the MHC in United Kingdom families.
Fernando MM; Stevens CR; Sabeti PC; Walsh EC; McWhinnie AJ; Shah A; Green T; Rioux JD; Vyse TJ
PLoS Genet; 2007 Nov; 3(11):e192. PubMed ID: 17997607
[TBL] [Abstract][Full Text] [Related]
16. Population and family studies of HLA-DR4 by use of oligonucleotide typing.
Reed E; Lupu F; McManus P; Seigle R; Suciu-Foca N
Tissue Antigens; 1992 May; 39(5):266-71. PubMed ID: 1412412
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR2-DRB1 allele frequencies in DR2-positive black Americans with and without systemic lupus erythematosus.
Reveille JD; Barger BO; Hodge TW
Tissue Antigens; 1991 Oct; 38(4):178-80. PubMed ID: 1801308
[No Abstract] [Full Text] [Related]
18. Association of HLA haplotype with keloids in Chinese Hans.
Lu WS; Zuo XB; Wang ZX; Cai LQ; Zhu F; Li Y; Zheng HF; Sun LD; Yang S; Zhang XJ
Burns; 2011 Aug; 37(5):794-9. PubMed ID: 21376472
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB3*0101 is associated with Graves' disease in Jamaicans.
Smikie MF; Pascoe RW; Barton E; Morgan O; Christian N; Dowe G; Roye-Green K; Bailey V; James O
Clin Endocrinol (Oxf); 2001 Dec; 55(6):805-8. PubMed ID: 11895223
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to raised dermal scarring.
Brown JJ; Bayat A
Br J Dermatol; 2009 Jul; 161(1):8-18. PubMed ID: 19508304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
